Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of bariatric surgery on plasma GDF15 in humans

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. IL-6 release from muscles during exercise is stimulated by lactate-dependent protease activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Multidisciplinær håndtering af svær jernforgiftning som følge af suicidalforsøg

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Bariatric surgery results in marked body weight loss and improves type 2 diabetes in most patients with obesity. The growth differentiation factor 15 (GDF15) has recently emerged as a novel satiety factor. To begin to understand whether GDF15 is involved in mediating the effects of bariatric surgery on body weight and glycemia in humans, we measured plasma GDF15 in patients with obesity ( n = 25) and in patients with obesity and diabetes ( n = 22) before and after Roux-en-Y gastric bypass (RYGB) surgery. GDF15 was increased 1 wk after RYGB compared with before surgery (689 ± 45 vs. 487 ± 28 pg/ml, P < 0.001) and GDF15 remained elevated at 3 mo (554 ± 37 pg/ml, P < 0.05), at 1 yr (566 ± 37 pg/ml, P < 0.05), and at 2.5-4 yr (630 ± 50 pg/ml, P < 0.001) after RYGB surgery. Both age and insulin sensitivity correlated with GDF15 before the surgery ( r = 0.46, P < 0.0001 and r = 0.34, P < 0.001, respectively). These correlations disappeared at 2.5-4 yr following the surgery. Conversely, weight loss magnitude correlated with GDF15, measured 2.5-4 yr postsurgery ( r = 0.21, P < 0.0055). In summary, circulating GDF15 increases and correlates with body weight loss following RYGB surgery.

Original languageEnglish
JournalAmerican Journal of Physiology: Endocrinology and Metabolism
Volume316
Issue number4
Pages (from-to)E615-E621
ISSN0193-1849
DOIs
Publication statusPublished - 1 Apr 2019

    Research areas

  • bariatric surgery, diabetes, GDF15, obesity, Roux-en-Y gastric bypass, Obesity, Bariatric surgery, Diabetes

ID: 56478607